Definium Therapeutics (DFTX) had the highest return in Q1 2020 by a mid-cap US stock, returning 900%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | Q1 2020 | 900% |
Novavax (NVAX) | Q1 2020 | 240.35% |
Aura Minerals Inc Common Shares (AUGO) | Q1 2020 | 107.12% |
Schrodinger (SDGR) | Q1 2020 | 65.85% |
Acm Research (ACMR) | Q1 2020 | 58.09% |
Youdao (DAO) | Q1 2020 | 49.43% |
Kiniksa Pharmaceuticals (KNSA) | Q1 2020 | 39.33% |
Arcus Biosciences (RCUS) | Q1 2020 | 37.43% |
Virtu Financial (VIRT) | Q1 2020 | 31.57% |
Arcutis Biotherapeutics (ARQT) | Q1 2020 | 29.23% |
Chewy (CHWY) | Q1 2020 | 27.86% |
Ringcentral (RNG) | Q1 2020 | 24.65% |
Zai Lab (ZLAB) | Q1 2020 | 23.31% |
Enphase Energy (ENPH) | Q1 2020 | 22.45% |
Qiagen (QGEN) | Q1 2020 | 21.32% |
Bilibili (BILI) | Q1 2020 | 20.29% |
iRhythm Technologies (IRTC) | Q1 2020 | 18.45% |
Five9 (FIVN) | Q1 2020 | 15.67% |
Palomar (PLMR) | Q1 2020 | 14.94% |
Enliven Therapeutics (ELVN) | Q1 2020 | 14.5% |
DraftKings (DKNG) | Q1 2020 | 14.37% |
Cytokinetics (CYTK) | Q1 2020 | 10.81% |
Plug Power (PLUG) | Q1 2020 | 10.28% |
TAL Education (TAL) | Q1 2020 | 10.06% |
GDS (GDS) | Q1 2020 | 9.87% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.